Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2020-02-28 | 2020-01-10 |
| Drug Identification Number | 02187078 | 02187078 |
| Brand name | HAVRIX - SUS IM 1440 ELISA UNITS/ML | HAVRIX - SUS IM 1440 ELISA UNITS/ML |
| Common or Proper name | hepatitis A vaccine, inactivated | hepatitis A vaccine, inactivated |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | HEPATITIS A VACCINE, INACTIVATED | HEPATITIS A VACCINE, INACTIVATED |
| Strength(s) | 1440UNIT | 1440UNIT |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 1's (prefilled syringe / seringue préremplie) | 1's (prefilled syringe / seringue préremplie) |
| ATC code | J07BC | J07BC |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2020-01-06 | 2020-01-06 |
| Estimated end date | Unknown | 2020-02-24 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Inventory on allocation to support demand in private market. Supply available for public programs. | Supply unavailable in the private market. Supply available for public programs. |
| Health Canada comments |